1-[(6-Methylpyridin-3-yl)methyl]-1H-1,2,4-triazol-3-amine

Catalog No.: 
ACLWOO606
CAS No.: 
1858043-22-7
Molecular Formula: 
C9H11N5
Molecular Weight: 
189.22
1-[(6-Methylpyridin-3-yl)methyl]-1H-1,2,4-triazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$245.00InquiryInquiry
1g95%$738.00InquiryInquiry
5g95%$3653.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(6-Methylpyridin-3-yl)methyl]-1H-1,2,4-triazol-3-amine
IUPAC Name1-((6-methylpyridin-3-yl)methyl)-1H-1,2,4-triazol-3-amine
Molecular FormulaC9H11N5
Molecular Weight189.22
SMILESNC1=NN(CC2=CC=C(C)N=C2)C=N1
InChI KeyGXIKQBGMPKVSFI-UHFFFAOYSA-N
Synonym1H-1,2,4-Triazol-3-amine, 1-[(6-methyl-3-pyridinyl)methyl]-
CAS No.1858043-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLWOO606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXUF847 route compound structure diagram
    ACJXUF847106651-81-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLWOO606 route product structure diagram
    ACLWOO6061858043-22-7
Inquiry

2. ACLWOO606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSEVW109 route compound structure diagram
    ACSEVW109718608-10-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLWOO606 route product structure diagram
    ACLWOO6061858043-22-7
Inquiry

3. ACLWOO606 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLWOO606 route product structure diagram
    ACLWOO6061858043-22-7
Inquiry

Comments (0)